Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance

被引：0
|
作者：
C Palmieri
O Gojis
B Rudraraju
C Stamp-Vincent
D Wilson
S Langdon
C Gourley
D Faratian
机构：
[1] Institute of translational Medicine,Department of Molecular and Clinical Cancer Medicine
[2] University of Liverpool,Division of Cancer
[3] Cancer Research UK Laboratories,Edinburgh Breakthrough Research Unit and Division of Pathology
[4] Imperial College London,undefined
[5] Du Cane Road,undefined
[6] London,undefined
[7] UK,undefined
[8] University of Edinburgh,undefined
[9] University of Edinburgh Cancer Research UK Centre,undefined
[10] Institute of Genetics and Molecular Medicine,undefined
[11] University of Edinburgh,undefined
来源：
British Journal of Cancer | 2013年 / 108卷
关键词：
ovarian cancer; SRC3; platinum; resistance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：2039 / 2044
页数：5
相关论文
共 50 条
  • [1] Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
    Palmieri, C.
    Gojis, O.
    Rudraraju, B.
    Stamp-Vincent, C.
    Wilson, D.
    Langdon, S.
    Gourley, C.
    Faratian, D.
    [J]. BRITISH JOURNAL OF CANCER, 2013, 108 (10) : 2039 - 2044
  • [2] Steroid and Xenobiotic Receptor (SXR) as a possible prognostic marker in epithelial ovarian cancer
    Yue, Xiaoni
    Akahira, Jun-ichi
    Utsunomiya, Hiroki
    Miki, Yasuhiro
    Takahashi, Naomi
    Niikura, Hitoshi
    Ito, Kiyoshi
    Sasano, Hironobu
    Okamura, Kunihiro
    Yaegashi, Nobuo
    [J]. PATHOLOGY INTERNATIONAL, 2010, 60 (05) : 400 - 406
  • [3] SERPINB3 in the Chicken Model of Ovarian Cancer: A Prognostic Factor for Platinum Resistance and Survival in Patients with Epithelial Ovarian Cancer
    Lim, Whasun
    Kim, Hee Seung
    Jeong, Wooyoung
    Ahn, Suzie E.
    Kim, Jinyoung
    Kim, Yong Beom
    Kim, Min A.
    Kim, Mi-Kyung
    Chung, Hyun Hoon
    Song, Yong Sang
    Bazer, Fuller W.
    Han, Jae Yong
    Song, Gwonhwa
    [J]. PLOS ONE, 2012, 7 (11):
  • [4] Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
    Lenhard, Miriam
    Tereza, Lennerova
    Heublein, Sabine
    Ditsch, Nina
    Himsl, Isabelle
    Mayr, Doris
    Friese, Klaus
    Jeschke, Udo
    [J]. BMC CANCER, 2012, 12
  • [5] Steroid hormone receptor expression in ovarian cancer: progesterone receptor B as prognostic marker for patient survival
    Miriam Lenhard
    Lennerová Tereza
    Sabine Heublein
    Nina Ditsch
    Isabelle Himsl
    Doris Mayr
    Klaus Friese
    Udo Jeschke
    [J]. BMC Cancer, 12
  • [6] Predicting platinum resistance and poor prognosis in patients with epithelial ovarian cancer
    Amjad, Maryam
    [J]. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2024,
  • [7] GENE EXPRESSION PROFILE AS A PROGNOSTIC MARKER IN EPITHELIAL OVARIAN CANCER
    Gebbia, F.
    Eusebi, M.
    Tassi, R.
    Gambino, A.
    Odicino, F.
    Sartori, E.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [8] High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer
    Pei-yuan Qiu
    Xi-han Deng
    Li Li
    [J]. Clinical and Translational Oncology, 2023, 25 : 1340 - 1352
  • [9] High expression of CETN2 is associated with platinum resistance and poor prognosis in epithelial ovarian cancer
    Qiu, Pei-yuan
    Deng, Xi-han
    Li, Li
    [J]. CLINICAL & TRANSLATIONAL ONCOLOGY, 2023, 25 (05): : 1340 - 1352
  • [10] Expression of progesterone receptor is a favorable prognostic marker in ovarian cancer
    Lee, P
    Rosen, DG
    Zhu, CC
    Silva, EG
    Liu, JS
    [J]. GYNECOLOGIC ONCOLOGY, 2005, 96 (03) : 671 - 677
12345